GRI BIO INC(GRI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GRI GRI BIO INC

休市中 05-09 16:00:00 EDT

1.47

-0.13

-8.12%

盘后1.51

+0.04+2.71%

19:57 EDT

最高1.65	最低1.45	成交量13.62万
今开1.62	昨收1.60	日振幅12.50%
总市值281.39万	流通市值281.30万	总股本191.42万
成交额21.19万	换手率7.12%	流通股本191.36万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GRI","market":"US","secType":"STK","nameCN":"GRI BIO INC","latestPrice":1.47,"timestamp":1746820800000,"preClose":1.6,"halted":0,"volume":136183,"hourTrading":{"tag":"盘后","latestPrice":1.5099,"preClose":1.47,"latestTime":"19:57 EDT","volume":4769,"amount":7171.6038,"timestamp":1746835079957},"delay":0,"floatShares":1913600,"shares":1914199,"eps":-55.205753,"marketStatus":"休市中","change":-0.13,"latestTime":"05-09 16:00:00 EDT","open":1.62,"high":1.65,"low":1.45,"amount":211928.6110418,"amplitude":0.125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-55.205753,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"RDOG","executeDate":"2020-01-02"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.6,"sharesOutstanding":1100000,"nav":47.93,"aum":52503274.57,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":1.61,"preClose":1.6,"latestTime":"09:24 EDT","volume":6007,"amount":9678.2357172,"timestamp":1746797081116},"postHourTrading":{"tag":"盘后","latestPrice":1.5099,"preClose":1.47,"latestTime":"19:57 EDT","volume":4769,"amount":7171.6038,"timestamp":1746835079957},"volumeRatio":0.308634},"requestUrl":"/m/hq/s/GRI","defaultTab":"news","newsList":[{"id":"2534437147","title":"Gri Bio, Inc.盘中异动 临近午盘股价大跌6.25%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534437147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534437147?lang=zh_cn&edition=full","pubTime":"2025-05-09 23:51","pubTimestamp":1746805888,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日23时51分，Gri Bio, Inc.股票出现波动，股价大幅下挫6.25%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为2.67%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。GRI Bio 的主导项目 GRI-0621 是一种小分子 RAR-β 和 γ 双重激动剂，可抑制人类 NKT I 细胞的活性，使免疫系统恢复稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509235133a6d94b19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509235133a6d94b19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2533372136","title":"Gri Bio, Inc.盘中异动 早盘股价大跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533372136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533372136?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:31","pubTimestamp":1746711110,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时31分，Gri Bio, Inc.股票出现波动，股价快速下挫5.55%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.65%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。GRI Bio 的主导项目 GRI-0621 是一种小分子 RAR-β 和 γ 双重激动剂，可抑制人类 NKT I 细胞的活性，使免疫系统恢复稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213150a476cf1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213150a476cf1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2533556954","title":"Gri Bio, Inc.盘中异动 下午盘大幅跳水5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533556954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533556954?lang=zh_cn&edition=full","pubTime":"2025-05-08 01:22","pubTimestamp":1746638541,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日01时22分，Gri Bio, Inc.股票出现波动，股价大幅跳水5.76%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。GRI Bio 的主导项目 GRI-0621 是一种小分子 RAR-β 和 γ 双重激动剂，可抑制人类 NKT I 细胞的活性，使免疫系统恢复稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050801222197522e40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050801222197522e40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2533536207","title":"Gri Bio, Inc.盘中异动 早盘快速下挫6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533536207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533536207?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:34","pubTimestamp":1746452046,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时34分，Gri Bio, Inc.股票出现异动，股价大幅下跌6.19%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。GRI Bio 的主导项目 GRI-0621 是一种小分子 RAR-β 和 γ 双重激动剂，可抑制人类 NKT I 细胞的活性，使免疫系统恢复稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050521340694ecf270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050521340694ecf270&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2532844256","title":"Gri Bio, Inc.盘中异动 早盘快速上涨5.13%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532844256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532844256?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:32","pubTimestamp":1746192731,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时32分，Gri Bio, Inc.股票出现异动，股价大幅上涨5.13%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。GRI Bio 的主导项目 GRI-0621 是一种小分子 RAR-β 和 γ 双重激动剂，可抑制人类 NKT I 细胞的活性，使免疫系统恢复稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213211a47003bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213211a47003bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2532049900","title":"Gri Bio, Inc.盘中异动 股价大涨5.49%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532049900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532049900?lang=zh_cn&edition=full","pubTime":"2025-05-01 23:14","pubTimestamp":1746112475,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日23时14分，Gri Bio, Inc.股票出现波动，股价快速拉升5.49%。截至发稿，该股报1.92美元/股，成交量4.4086万股，换手率6.06%，振幅5.49%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050123143594ea040b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050123143594ea040b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"2531751873","title":"Gri Bio, Inc.盘中异动涨2.25% 振幅达11.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531751873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531751873?lang=zh_cn&edition=full","pubTime":"2025-04-29 22:41","pubTimestamp":1745937664,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日22时41分，Gri Bio, Inc.股票出现波动，股价急速拉升2.25%。截至发稿，该股报1.82美元/股，成交量7.7073万股，换手率10.60%，振幅11.24%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.12%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042922410494e7b0a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042922410494e7b0a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2530281229","title":"Gri Bio, Inc.盘中异动 股价大涨5.49%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530281229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530281229?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:54","pubTimestamp":1745848496,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时54分，Gri Bio, Inc.股票出现波动，股价急速拉升5.49%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428215456a6cbc5d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428215456a6cbc5d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2530139067","title":"Gri Bio, Inc.盘中异动 快速上涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530139067?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:45","pubTimestamp":1745588754,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时45分，Gri Bio, Inc.股票出现异动，股价急速上涨5.40%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。GRI Bio 的主导项目 GRI-0621 是一种小分子 RAR-β 和 γ 双重激动剂，可抑制人类 NKT I 细胞的活性，使免疫系统恢复稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425214554a6c82016&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425214554a6c82016&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2529153586","title":"Gri Bio, Inc.盘中异动 大幅上涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529153586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529153586?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:37","pubTimestamp":1745329052,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时37分，Gri Bio, Inc.股票出现异动，股价快速拉升6.16%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。消息层面，截至21时37分，《Ascendiant Capital：维持GRI Bio评级，由买入调整至买入评级, 目标价由221.00美元调整至40.00美元。》资讯为影响Gri Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221373294de33fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221373294de33fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2529331929","title":"Gri Bio, Inc.盘中异动 下午盘快速下跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529331929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529331929?lang=zh_cn&edition=full","pubTime":"2025-04-22 02:43","pubTimestamp":1745261004,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日02时43分，Gri Bio, Inc.股票出现异动，股价急速下挫5.63%。Gri Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。消息层面，截至02时43分，《Ascendiant Capital：维持GRI Bio评级，由买入调整至买入评级, 目标价由221.00美元调整至40.00美元。》资讯为影响Gri Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422024325aa2c7520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422024325aa2c7520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2529874083","title":"Ascendiant Capital：维持GRI Bio评级，由买入调整至买入评级, 目标价由221.00美元调整至40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874083","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529874083?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:51","pubTimestamp":1745232694,"startTime":"0","endTime":"0","summary":"Ascendiant Capital：维持GRI Bio(GRI.US)评级，由买入调整至买入评级, 目标价由221.00美元调整至40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042118541494dcc69a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042118541494dcc69a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI"],"gpt_icon":0},{"id":"2527417639","title":"Gri Bio, Inc.盘中异动 股价大涨5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527417639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527417639?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:46","pubTimestamp":1744724818,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时46分，Gri Bio, Inc.股票出现波动，股价快速拉升5.83%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。GRI Bio 的主导项目 GRI-0621 是一种小分子 RAR-β 和 γ 双重激动剂，可抑制人类 NKT I 细胞的活性，使免疫系统恢复稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214658a6bb4f76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214658a6bb4f76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2526761489","title":"Gri Bio, Inc.盘中异动 股价大涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526761489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526761489?lang=zh_cn&edition=full","pubTime":"2025-04-12 02:09","pubTimestamp":1744394946,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日02时09分，Gri Bio, Inc.股票出现异动，股价大幅拉升5.79%。Gri Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.52%。Gri Bio, Inc.公司简介：GRI Bio Inc 是一家临床阶段的生物技术公司，专注于发现、开发和商业化针对与免疫反应失调相关的严重疾病的创新疗法，这些疾病会导致炎症、纤维化和自身免疫性疾病。GRI Bio 的主导项目 GRI-0621 是一种小分子 RAR-β 和 γ 双重激动剂，可抑制人类 NKT I 细胞的活性，使免疫系统恢复稳态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041202090797359716&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041202090797359716&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2502792884","title":"巴斯夫MDI在东盟和南亚地区提价 每吨售价提高300美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502792884","media":"慧聪化工网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502792884?lang=zh_cn&edition=full","pubTime":"2025-01-10 14:11","pubTimestamp":1736489460,"startTime":"0","endTime":"0","summary":"慧正资讯，巴斯夫宣布自1月7日起，对其MDI在东盟地区和南亚地区进行提价，本次提价幅度为300美元/吨。巴斯夫称，此次提价的原因是物流运输、能源和监管成本的持续增长，为维持正常运营做出的必要提价。在功能性化学品领域，海名斯在2024年12月宣布将在2025年1月15日起，执行提价后的销售价格，以此应对通胀带来的成本增加。阳明海运计划上调综合费率附加费，美西和美东每40英尺集装箱的涨幅均约为2000美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-10/doc-ineeniac5682031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","BK4139","BK4575","MSC","BK4150","GRI"],"gpt_icon":0},{"id":"2491502879","title":"聚焦上市公司可持续发展报告“双重重要性” 需厘清编制过程中的“因为-所以”","url":"https://stock-news.laohu8.com/highlight/detail?id=2491502879","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491502879?lang=zh_cn&edition=full","pubTime":"2024-12-15 22:18","pubTimestamp":1734272280,"startTime":"0","endTime":"0","summary":"　　年关将至，上市公司新一轮的可持续发展报告披露工作启动在即。11月，三大交易所发布《可持续发展报告编制》，其中一个重大工作内容便是提出了“双重重要性”的识别、分析和披露的要求。本文结合两大重要性的发展、一揽子配套制度，以及欧盟《可持续发展报告准则》和我国三大交易所《可持续发展报告编制》中对“双重重要性”的关注，试图厘清在可持续发展报告编制过程中的“因为-所以”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-12-15/doc-inczqiim3309007.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-15/doc-inczqiim3309007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ESG","GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2490677844","title":"赫伯罗特上调中东和印度次大陆至北美运价","url":"https://stock-news.laohu8.com/highlight/detail?id=2490677844","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490677844?lang=zh_cn&edition=full","pubTime":"2024-12-12 10:29","pubTimestamp":1733970560,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["BK4139","BK4007","GRA","GRI"],"gpt_icon":0},{"id":"2490711873","title":"稳健医疗：全棉时代已回归到健康的可持续增长态势","url":"https://stock-news.laohu8.com/highlight/detail?id=2490711873","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490711873?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:18","pubTimestamp":1733728704,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300888","BK4007","BK0247","GRI","BK4139","159891"],"gpt_icon":0},{"id":"2478398345","title":"新股消息 | 科望医药集团拟港股IPO 证监会备案状态为“补充材料“","url":"https://stock-news.laohu8.com/highlight/detail?id=2478398345","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478398345?lang=zh_cn&edition=full","pubTime":"2024-10-25 19:20","pubTimestamp":1729855254,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月25日，中国证监会发布《境内企业境外发行证券和上市备案情况表》，其中，科望医药集团在中国证监会上市备案状态为\"补充材料\"。招股书显示，科望医药集团是一家于2017年成立的处于临床阶段的生物医药公司，致力于全球范围内利用新一代疗法创新肿瘤治疗。财务方面，于2022年、2023年，科望医药集团研发成本分别约为3.51亿元、1.08亿元人民币;同期年内亏损及全面亏损总额分别约为7.71亿元、8.53亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","GRI","HSCEI","YANG"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vallon-pharma.com","stockEarnings":[{"period":"1week","weight":-0.3},{"period":"1month","weight":0.1308},{"period":"3month","weight":-0.8195},{"period":"6month","weight":-0.9012},{"period":"1year","weight":-0.9837},{"period":"ytd","weight":-0.8956}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0606},{"period":"6month","weight":-0.0566},{"period":"1year","weight":0.0849},{"period":"ytd","weight":-0.0371}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GRI Bio, Inc.于2018年1月11日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对与导致炎症、纤维化和自身免疫性疾病的失调免疫反应相关的严重疾病的创新疗法。该公司的目标是成为开发治疗这些疾病的疗法的行业领导者，并改善患有此类疾病的患者的生活。","exchange":"NASDAQ","name":"GRI BIO INC","nameEN":"GRI BIO INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRI BIO INC(GRI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRI BIO INC(GRI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRI BIO INC,GRI,GRI BIO INC股票,GRI BIO INC股票老虎,GRI BIO INC股票老虎国际,GRI BIO INC行情,GRI BIO INC股票行情,GRI BIO INC股价,GRI BIO INC股市,GRI BIO INC股票价格,GRI BIO INC股票交易,GRI BIO INC股票购买,GRI BIO INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRI BIO INC(GRI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRI BIO INC(GRI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}